Alemtuzumab and anorexia Patient Reports March 21, 2010



Alemtuzumab Side Effects Report #5926342-6
Alemtuzumab side effect was reported by a Physician from GERMANY on July 04, 2008. Male patient, 68 years of age, weighting 160.9 lb, was diagnosed with chronic lymphocytic leukaemia recurrent, pain What is  pain, infection What is  infection, dyspepsia and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: actinomycosis, anorexia, oropharyngeal pain. Alemtuzumab dosage: unknown. During the same period patient was treated with FLUDARABINE, CYCLOPHOSPHAMIDE, LEVOTHYROXINE, DICLOFENAC, MEROPENEM, TEPILTA, ZOPICLON. Patient was hospitalized. Patient recovered.

Alemtuzumab Side Effects Report #5929053-6
Alemtuzumab side effect was reported by a Physician from GERMANY on July 04, 2008. Male patient, 68 years of age, weighting 160.9 lb, was diagnosed with chronic lymphocytic leukaemia recurrent, pain What is  pain, infection What is  infection, dyspepsia and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: actinomycosis, anorexia, oropharyngeal pain. Alemtuzumab dosage: unknown. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOPHOSPHAMIDE, LEVOTHYROXINE, DICLOFENAC, MEROPENEM, TEPILTA, ZOPICLON. Patient was hospitalized. Patient recovered.

Alemtuzumab Side Effects Report #5693648-8
Alemtuzumab side effect was reported by a Physician from GERMANY on Mar 28, 2008. Female patient, 74 years of age, was diagnosed with b-cell small lymphocytic lymphoma, prophylaxis and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: anorexia, aphasia What is  aphasia, central nervous system lymphoma, dizziness What is  dizziness, encephalitis What is  encephalitis, nausea What is  nausea, weight decreased. Alemtuzumab dosage: unknown. During the same period patient was treated with FLUDARABINE, CYCLOPHOSPHAMIDE, TAVEGIL, PREDNISOLONE, ACETAMINOPHEN, KEVATRIL, DEXAMETHASONE, UROMITEXAN. Patient was hospitalized. Patient died on 03/12/2008.

Alemtuzumab Side Effects Report #6114582-5
Alemtuzumab side effect was reported by a Physician from GERMANY on Mar 06, 2009. Female patient, 74 years of age, was diagnosed with b-cell small lymphocytic lymphoma, prophylaxis and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: anorexia, aphasia What is  aphasia, central nervous system lymphoma, dizziness What is  dizziness, encephalitis What is  encephalitis, metastases to central nervous system, nausea What is  nausea, oral herpes. Alemtuzumab dosage: unknown. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOPHOSPHAMIDE, TAVEGIL, PREDNISOLONE, PARACETAMOL, KEVATRIL, DEXAMETHASONE, UROMITEXAN. Patient was hospitalized. Patient died on 03/12/2008.
SideEffects101.com does not provide medical advice, diagnosis or treatment. The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Thank you for visiting SideEffects101.com and reading about

side effects of Alemtuzumab